| Rachel Teranishi, MD | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (205) 934-3450 | |
| Not Available |
| Full Name | Rachel Teranishi |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Brain Injury Medicine |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437684404 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 44467 (Alabama) | Secondary |
| 2081P0301X | Physical Medicine & Rehabilitation - Brain Injury Medicine | 44467 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The Austrian Breast & Colorectal Cancer Study Group, Alliance Foundation Trials, the Breast International Group, PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study trial determined that the study is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival following a preplanned interim analysis.
Addictive behaviour is determined by conscious, rapid thought processes, not necessarily by the content of visual stimuli as previously thought according to research funded by the Biotechnology and Biological Sciences Research Council (BBSRC).
Similar genetic variations occur in both overweight newborns and obese adults, a large study finds.
An invention by Florida Institute of Technology's Shengyuan Yang was found to naturally narrow the spreading of stem cells and has the potential to induce and regulate their differentiation.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Teranishi, MD 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (205) 934-3450 | Rachel Teranishi, MD 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (205) 934-3450 |
News Archive
The Austrian Breast & Colorectal Cancer Study Group, Alliance Foundation Trials, the Breast International Group, PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study trial determined that the study is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival following a preplanned interim analysis.
Addictive behaviour is determined by conscious, rapid thought processes, not necessarily by the content of visual stimuli as previously thought according to research funded by the Biotechnology and Biological Sciences Research Council (BBSRC).
Similar genetic variations occur in both overweight newborns and obese adults, a large study finds.
An invention by Florida Institute of Technology's Shengyuan Yang was found to naturally narrow the spreading of stem cells and has the potential to induce and regulate their differentiation.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
› Verified 5 days ago
Charles R Law, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3944 Fax: 205-413-4914 | |
Keneshia Kirksey, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Charles Carnel, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 805 Saint Vincents Dr, Birmingham, AL 35205 Phone: 205-939-3699 Fax: 205-581-7155 | |
Lonnie Blake Dorcey, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1201 3rd Ave N Ste B, Birmingham, AL 35203 Phone: 256-546-8127 Fax: 256-547-6720 | |
Dr. Srinivas Mallempati, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 | |
Elizabeth Chantal Twist, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Leesa D Miles, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 4th Ave S, Birmingham, AL 35233 Phone: 205-263-5800 Fax: 205-263-5850 |